Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020672 (hypothermia)
 17,327 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Sulfolane dosages that alter seizure susceptibility were determined using audiogenic (AG), pentylenetetrazol (PTZ) and hippocampal afterdischarge (AD) seizure models. The presence of AG seizures and potentiation of PTZ seizures were investigated in rats injected IP with 0, 200, 400 or 800 mg/kg; AD activity was assessed only at the highest and lowest dosages. The dose-dependent hypothermia associated with sulfolane treatment was controlled in Experiment I and a replication study (Experiment II) by testing under isothermic conditions. The effect of body temperature was measured directly in Experiment III by comparing AG seizure incidence and characteristics exhibited by hypothermic and normothermic animals. Audiogenic seizures were elicited in nearly half of the 800 mg/kg animals in both Experiments I and II. Sulfolane-induced hypothermia, maximal at 3 hours, partially protected against AG seizure characteristics. Potentiation of PTZ seizure severity (800 mg/kg) and duration (800 and 400 mg/kg) also were observed. None of the hippocampal AD parameters was affected significantly by sulfolane treatment. The similarity of the convulsants sulfolane and PTZ is discussed.
 ...
PMID:Sulfolane effects on audiogenic, pentylenetetrazol and afterdischarge seizure activity. 380 77

Sulfolane (tetrahydrothiophene-1, 1-dioxide) is a commercially important solvent. This report describes the consequences of acute exposure to sulfolane upon the visual system, as measured using flash evoked potentials (FEPs) and pattern reversal evoked potentials (PREPs). A single injection of either 1/2 or 1/4, but not 1/8 the IP LD50 (1600 mg/kg) produced significant changes in both FEPs and PREPs which were apparent within 1 hour and lasted longer than 6 hours. Amplitudes of FEP peaks to the first of a pair of stimuli were generally increased compared to control, an effect which was not temperature-dependent. In addition, sulfolane produced an ambient temperature- and dose-dependent hypothermia. Sulfolane increased latencies of FEP and PREP peaks, but attenuating hypothermia eliminated the effect of sulfolane on latencies.
 ...
PMID:Acute sulfolane exposure produces temperature-independent and dependent changes in visual evoked potentials. 380 84

Sulfolane is a solvent which produces hypothermia and decreased oxygen consumption following acute exposure. In the present experiment, we investigated effects of sulfolane on a behavioral measure of toxicity at ambient temperatures which would either prevent or facilitate the development of hypothermia. Adult male Long-Evans rats (N = 10/dose) received a single i.p. injection of saline, 200, 400 or 800 mg/kg sulfolane. Motor activity in figure-of-eight mazes was assessed 1 h after dosing in testing rooms maintained at either 20.8 degrees C or at 32.3 degrees C. At the warm ambient temperature, sulfolane produced hypoactivity but not hypothermia. At the cooler temperature, sulfolane-induced hypoactivity was more pronounced, and rats were hypothermic. Therefore, a behavioral change could be detected at sublethal dosages of sulfolane in the absence of hypothermia.
 ...
PMID:Acute behavioral toxicity of sulfolane: influence of hypothermia. 407 60

Sulfolane (tetrahydrothiophene 1,1-dioxide), a commonly used extraction solvent, promotes rapid changes in the thermoregulatory system. Colonic temperature, skin temperature, metabolic rate, and preferred ambient temperature (Ta) were measured over an 8-h period in the Sprague-Dawley rat following an intraperitoneal injection of sulfolane at 800 mg/kg or of physiological saline. At Ta values of 15 and 25 degrees C, sulfolane caused a significant inhibition in metabolic rate and reduction in colonic temperature, which lasted over the 8-h measuring period. At both Ta values, metabolic rate tended to recover approximately 4 h after sulfolane injection. Colonic temperature recovered with time but was still significantly reduced at 8 h postinjection. Tail skin temperature was unaffected. Preferred Ta in the sulfolane-treated rat was not significantly different from the controls. In spite of their hypothermic condition, the sulfolane-treated animals did not select a warm Ta. Since sulfolane toxicity appears to be greater with increased tissue temperature, the sulfolane-induced hypothermia may enhance survival of the rat following exposure to toxic levels of sulfolane.
 ...
PMID:Effect of sulfolane on behavioral and autonomic thermoregulation in the rat. 408 12

Sulfolane toxicity may be partially due to its effects on body temperature. To examine the effects of sulfolane on thermoregulation, we measured metabolic rate (oxygen uptake) and body temperature in rats injected intraperitoneally with sulfolane at dosages of 0, 200, 400, and 800 mg/kg. At ambient temperatures (Ta) of 15 and 25 degrees C sulfolane caused a dose-related inhibition of metabolic rate accompanied by hypothermia 60 min post-injection. At a Ta of 35 degrees C, sulfolane had no effect on body temperature or metabolic rate. The hypometabolic and hypothermic effect of sulfolane at a Ta of 25 degrees C at least 2.5 h. Sulfolane had near identical effects on body temperature at TaS of 15 and 25 degrees C, hence, the sulfolane-treated rat had some control over body temperature at a relatively low Ta.
 ...
PMID:Effect of ambient temperature on the hypometabolic and hypothermic effects of sulfolane in rats. 653 77